• Home
  • Millersville University of Pennsylvania
  • Fundamentals Of SpeechCOMM 100
  • Misinformation in Media and Prescription Drug Costs

Misinformation in Media and Prescription Drug Costs

- Media is a such a tricky median to get information nowadays and for many people, they just take headlines at face value. Many people just see a headline and just run with the information instead of wanting to fact check the information. Headlines are meant to grab peoples attention and people who work in the media know how to do this best. They make these scientific claims that are broad enough to catch their audiences attention and then briefly highlight parts of the article that support their claim even thought that is not what the original scientific journals intentions were. This creates a population of misinformed people who inherently take science as a joke. - In recent years, medication has become a great medical tool to help treat many different illnesses and diseases without having to constantly be at the doctors office. Over the years, prescription medication has risen drastically in price making it increasing harder for people to get the medication they need. As issue that has becoming more prevalent is the cost differential between brand name prescription drugs and generic versions. In an article released by studyfinds.com, a website that is made to present factual data from scientific journals in a way that does not misconstrue the intent of the journal article itself, research was conducted are on brand-name prescriptions and why they are much more costly than the generic options. The article introduces the topic by explaining thought this research came from John Hopkins Bloomberg school of public health which conducted a study in 2017. The school public health is the one that states that $1.7 billion more is being spent on brand names versus generics. Right off the bat reduce or given figures without discussing the sample size and how many people were no involved in the study. Summarize article also states that the study finds that physician and patient request brand-name drugs over generic version 30% of the time. As a whole this article really throws a lot of different figures at the rear which can often be misconstrued and hard to understand. Makes big claims that a patient could've saved $161 million if doctors request a generic versions instead and includes that $106 million in tax dollars could've been saved if patient request of the generic versions instead of the namebrand. The 6% ask their physician for the more recognizable drugs versus any alternatives. It closes office saying that the drug prices in the United States are 2.56 higher than any of the other nations and that $4.42 billion have been spent on Brennan's prescriptions that were not specified by patients or physicians. Websites like this try to summarize the data in easy digestible mediums because they know their target audience. Their target audience is people who do not have time to sit and read entire Peerview journal article and may not be people who understand what the statistical analysis truly is saying. I think this article does a good job of summarizin